- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
911
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
911 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
3836 | HK$0.41 | -9.8% | -43.9% | HK$663.8m | HK$1.29 | PB0.1x | E68.1% | 15.2% | Retail | ||
PENG B | SEK 13.95 | -0.7% | 14.3% | SEK 335.6m | SEK 18.50 | PE69.3x | E49.3% | 0% | Commercial Services | ||
NRC | NOK 10.45 | -0.5% | -3.2% | NOK 761.4m | NOK 14.00 | PB0.3x | E93.2% | 0% | Capital Goods | ||
3854 | JP¥2,503.00 | -3.1% | 0.2% | JP¥65.5b | JP¥5,100.00 | PE21.4x | E12.3% | 1.6% | Software | ||
XRO | AU$135.61 | 2.3% | 11.0% | AU$21.4b | AU$149.33 | PE129.7x | E24.1% | n/a | Software | ||
ACRE | US$7.61 | 0.5% | -28.1% | US$421.2m | US$7.00 | PS11.3x | E150.4% | 13.1% | Diversified Financials | ||
TARSONS | ₹504.70 | -2.4% | -16.4% | ₹27.3b | ₹570.50 | PE63.6x | E20.3% | 0.4% | Pharmaceuticals & Biotech | ||
FXPO | UK£0.53 | -16.4% | -36.9% | UK£312.4m | UK£1.12 | PB0.4x | E70.8% | 0% | Materials | ||
FTI | US$28.80 | 1.5% | 57.8% | US$12.6b | US$29.85 | PE27.2x | E20.5% | 0.7% | Energy | ||
BELA | €24.74 | -0.2% | -7.1% | €3.4b | €34.01 | PE11.1x | E5.8% | 12.4% | Retail | ||
HOTEL * | Mex$4.00 | 4.4% | -2.0% | Mex$2.9b | Mex$5.50 | PE33.7x | E32.6% | n/a | Consumer Services | ||
PVRINOX | ₹1,470.85 | -1.5% | -9.0% | ₹146.2b | ₹1,704.42 | PS2.4x | E60.2% | 0% | Media | ||
300871 | CN¥9.31 | 5.1% | -44.3% | CN¥1.5b | n/a | PS1.5x | E60.4% | 2.9% | Pharmaceuticals & Biotech | ||
6820 | HK$0.52 | 4.0% | -37.3% | HK$1.2b | HK$1.44 | PB0.8x | E72.0% | 0% | Media | ||
1477 | HK$6.98 | 3.4% | -27.4% | HK$4.9b | HK$9.32 | PS18.2x | E93.7% | n/a | Pharmaceuticals & Biotech | ||
WSBC | US$30.59 | -10.8% | 11.7% | US$1.9b | US$34.29 | PB0.8x | E32.5% | 4.7% | Banks | ||
6805 | NT$735.00 | 6.4% | 310.6% | NT$53.7b | NT$1,047.14 | PE65x | E46.4% | 0.7% | Tech | ||
688793 | CN¥34.05 | 10.2% | -11.9% | CN¥2.8b | CN¥37.52 | PS2.1x | E64.5% | 0% | Household | ||
TER | US$121.74 | -2.1% | 13.2% | US$20.5b | US$145.63 | PE38.3x | E22.3% | 0.4% | Semiconductors | ||
4385 | JP¥1,978.00 | -9.7% | -45.8% | JP¥354.6b | JP¥2,900.42 | PE19.3x | E18.8% | n/a | Retail | ||
REG1V | €28.60 | -0.1% | 18.8% | €760.6m | €30.33 | PE41.1x | E17.1% | 1.3% | Healthcare | ||
EZTC3 | R$13.05 | -3.3% | -43.8% | R$2.8b | R$19.82 | PE11.2x | E23.9% | 2.0% | Consumer Durables | ||
PROB | SEK 269.00 | -1.1% | 46.2% | SEK 3.1b | n/a | PE223.7x | E50.0% | 0.5% | Pharmaceuticals & Biotech |